Transient Postoperative Hypoxemia Associated With Cannabis Use Following General Anesthesia
#67 Notable Clinical Interest
Emerging findings or policy developments worth monitoring closely.
Clinicians administering general anesthesia need to recognize cannabis use as a potential risk factor for postoperative hypoxemia, as cannabis-induced airway inflammation and impaired gas exchange can compound anesthesia-related respiratory depression. This finding should prompt preoperative screening for cannabis use, adjusted intraoperative ventilation strategies, and enhanced postoperative respiratory monitoring to prevent complications. Patients who use cannabis should be counseled to disclose this use before surgery and may benefit from extended recovery room observation to detect and manage transient oxygen desaturation.
This clinical case report describes a patient who developed significant postoperative hypoxemia following general anesthesia, with cannabis use identified as a contributing factor through its known effects on airway irritation, bronchial hyperreactivity, and alveolar inflammation. The mechanisms by which cannabis impairs gas exchange and increases airway reactivity create particular concern in the perioperative period when patients are already at risk for respiratory complications. The findings suggest that cannabis use history should be incorporated into preoperative risk assessment, as active or recent use may predispose patients to enhanced postoperative hypoxemic episodes. Anesthesiologists and surgeons should consider cannabis use as a modifiable risk factor when counseling patients about preoperative optimization and may need to employ enhanced respiratory monitoring protocols for affected patients. Clinicians should routinely ask patients about cannabis use during preoperative evaluation and counsel patients to abstain in the perioperative period to minimize preventable respiratory complications.
“This case report describing postoperative hypoxemia in a cannabis user is worth taking seriously as a clinical signal, but we need to be careful not to overstate what a single case tells us. What it does highlight is that we need better preoperative screening conversations about cannabis use, particularly inhalation methods, so we can optimize airway management and postoperative monitoring in these patients.”
💨 Perioperative cannabis use presents a potential respiratory risk that anesthesiologists should actively screen for during preoperative assessment. The underlying mechanisms—including airway irritation, bronchial hyperreactivity, and altered gas exchange—suggest that cannabis inhalation may compound the respiratory depression and airway complications already inherent to general anesthesia and recovery. However, distinguishing cannabis-specific effects from anesthesia-related causes of postoperative hypoxemia remains challenging, particularly given the variable frequency and intensity of patient cannabis use, concomitant tobacco exposure, and individual variation in airway sensitivity. Clinicians should counsel patients to abstain from cannabis use in the perioperative period when feasible and maintain a lower threshold for extended monitoring, supplemental oxygen, and pulmonary interventions in those unable or unwilling to abstain. A targeted preoperative history that quantifies cannabis use frequency and inhalation method, combined
This topic comes up in consultations often.
Dr. Caplan offers clinical context on evolving cannabis policy and its real-world implications for patients.
Book a consultation →💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
